Covered recipient · General Payments record
EMILY DENISE COTTRELL
Allopathic & Osteopathic Physicians Psychiatry & Neurology Child & Adolescent Psychiatry
General Payments · PY2018–2024
$1,323.87
- Reported across 59 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $173.65 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $60.06 | 3 |
| GlaxoSmithKline, LLC. | $45.53 | 3 |
| ABBVIE INC. | $32.87 | 1 |
| Abbott Laboratories | $18.83 | 1 |
| Acerta Pharma LLC | $16.36 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $18.83 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124807515 | CMS |
| ABBVIE INC. | $32.87 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103507686 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.36 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104445847 | CMS |
| GlaxoSmithKline, LLC. | $13.77 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116343322 | CMS |
| GlaxoSmithKline, LLC. | $15.30 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116645777 | CMS |
| GlaxoSmithKline, LLC. | $16.46 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116430011 | CMS |
| Novo Nordisk Inc | $16.66 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096858622 | CMS |
| Novo Nordisk Inc | $23.57 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097004659 | CMS |
| Novo Nordisk Inc | $19.83 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096938219 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.